TJP3 and endometrial cancer: Our study found that all but one of the cell lines showed overexpression of an additional three TJ genes: OCLN, F11R (JAM-A) and TJP3 (ZO-3), suggesting a more complex role for TJ deregulation in endometrial cancer involving proteins that function at different levels within the TJ network from cell to cell adhesion to cell signaling.